A weekly appointment with a medication can be easy to remember for one person and a constant chore for another. It makes sense to wonder whether injections could someday fit into a longer interval.
Researchers are studying that idea. But a longer interval is a convenience question as well as a safety and effectiveness question. A medicine still has to work over time, be tolerable and fit the needs of the people taking it.
What has been studied?
One phase 2 trial examined maridebart cafraglutide, sometimes called MariTide, using a monthly schedule. The study enrolled 592 adults across two groups: people with obesity and people with obesity and type 2 diabetes. Researchers compared active-treatment groups with placebo and reported weight changes at 52 weeks.
On average, the active groups lost more weight than the placebo groups. The results differed between the two populations and across study groups. Gastrointestinal adverse events were common.
That tells us something about this particular molecule and schedule in this trial. It doesn’t prove that changing the timing of an existing weekly prescription will produce the same result. It also wasn’t a direct comparison with every weekly medicine.
Does fewer injections mean better adherence?
It might feel simpler to someone who dislikes frequent injections or travels often. But a monthly routine can be easy to forget precisely because it happens less often. Someone else may find a weekly habit easier to remember.
Researchers would need to measure what actually happens in people’s lives: whether they take a treatment as intended, what gets in the way and whether a different schedule improves those patterns. Convenience can include appointment access, the device itself, cost and what support is available, not just how many dates appear on a calendar.
How long do effects and side effects last?
A longer-acting medicine is intended to have an effect across a longer interval. That raises practical questions. Does the effect stay consistent between administrations? What happens if someone needs to stop because of a side effect or another health issue? How long does the medicine remain in the body?
The answers depend on the specific molecule. It would be a mistake to assume every long-acting treatment behaves the same way or that a longer interval necessarily means worse or better tolerability.
In the monthly study, digestive effects were common. A helpful report should include those experiences alongside the weight result, as well as any reasons people discontinued treatment.
What would a stronger comparison look like?
Researchers can compare a new approach with placebo to see whether its outcomes differ from no active study medicine. A direct comparison with another treatment answers a different question. Even then, the people enrolled, the study duration and the outcomes measured all matter.
Putting the biggest figure from a monthly trial next to the biggest figure from a separate weekly trial is not a fair shortcut. The groups and methods may differ. A person’s response can differ from either average.
Other useful outcomes include quality of life, changes in blood sugar where relevant, tolerability and what happens after treatment changes. Those may matter as much to a patient as a single weight measurement.
What should you do with your current schedule?
Keep following the directions for the medicine prescribed to you. If remembering a weekly dose is difficult or the routine is uncomfortable, tell your prescriber. They can discuss options and help you make a plan specific to your treatment.
Don’t stretch an interval or combine doses to imitate a study schedule. Research protocols use a particular molecule and include monitoring; they aren’t instructions for other medicines.
Our guide to how long GLP-1 treatment might last looks at the broader question of ongoing care.
Fewer injections may be appealing. The best answer will depend on good evidence and on whether the whole routine works for the person using it.